Strategic Acquisition Opportunity LICORbio's recent acquisition of Serva Electrophoresis GmbH expands its portfolio of electrophoresis reagents and workflow instrumentation, presenting opportunities to cross-sell integrated imaging solutions with electrophoresis products to existing and new customers in research laboratories.
Innovation Leadership With over 100,000 citations and a reputation for reliable, accurate, and innovative imaging solutions, LICORbio positions itself as a preferred partner for institutions seeking cutting-edge research tools, opening avenues for premium product offerings and collaborative projects.
Market Expansion Potential Operating in the biotechnology research industry with a revenue range of 100M to 250M and a sizable workforce, LICORbio has significant capacity for scaling its sales efforts by targeting academic and industrial labs focusing on life sciences and human health.
Digital Engagement Channels Utilizing cloud and web technologies such as Google Cloud CDN, Amazon S3, and modern JavaScript frameworks indicates strong digital infrastructure, enabling targeted online marketing, demonstrations, and remote sales support to reach global research clients efficiently.
Growth through R&D Support LICORbio's focus on integrated software and reagent development suggests ongoing investments in research and development, giving sales teams opportunities to promote new product launches and tailored solutions to meet evolving scientific needs.